WOOP-SURPASS · Research portals
Indication research portals
One open portal per indication of the platform. Each maps the drug programs, the biology they act on and the organizations around them, compiled from public sources with every fact linked.
-
TNBC
Triple-negative breast cancer
The platform's launch population.
- Active programs344
- Discontinued programs333
- Organizations950
-
HR+/HER2−
HR+/HER2− breast cancer
A later stratum of the breast cancer platform.
- Active programs172
- Discontinued programs137
- Organizations671
-
PDAC
Pancreatic ductal adenocarcinoma
Under discussion as the platform's first copy outside breast cancer.
- Active programs360
- Discontinued programs241
- Organizations958
The seven maps
Every portal has the same seven maps, each with its data as CSV files and a column description in the data package.
- Pipeline landscape: every active program by approach and stage
- History map: active and discontinued programs over time
- Cell map: programs placed on the disease biology, step by step
- Who invests: private investors in companies with programs
- Big pharma: activity of the 50 largest pharma companies
- Foundations map: funding, data, samples and partnering support
- Researchers: researchers and the companies they advise